Issues In Cancer Drugs And Therapies 2013 Edition
Download Issues In Cancer Drugs And Therapies 2013 Edition full books in PDF, epub, and Kindle. Read online free Issues In Cancer Drugs And Therapies 2013 Edition ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: |
Publisher |
: ScholarlyEditions |
Total Pages |
: 282 |
Release |
: 2013-05-01 |
ISBN-10 |
: 9781490106199 |
ISBN-13 |
: 1490106197 |
Rating |
: 4/5 (99 Downloads) |
Synopsis Issues in Cancer Drugs and Therapies: 2013 Edition by :
Issues in Cancer Drugs and Therapies / 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Gene Therapy. The editors have built Issues in Cancer Drugs and Therapies: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Gene Therapy in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Cancer Drugs and Therapies: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Author |
: |
Publisher |
: ScholarlyEditions |
Total Pages |
: 278 |
Release |
: 2013-05-01 |
ISBN-10 |
: 9781490106229 |
ISBN-13 |
: 1490106227 |
Rating |
: 4/5 (29 Downloads) |
Synopsis Issues in Cancer Treatment and Therapy: 2013 Edition by :
Issues in Cancer Treatment and Therapy / 2013 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about Additional Research in a concise format. The editors have built Issues in Cancer Treatment and Therapy: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Additional Research in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Cancer Treatment and Therapy: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Author |
: |
Publisher |
: ScholarlyEditions |
Total Pages |
: 371 |
Release |
: 2012-01-09 |
ISBN-10 |
: 9781464967153 |
ISBN-13 |
: 1464967156 |
Rating |
: 4/5 (53 Downloads) |
Synopsis Issues in Cancer Drugs and Therapies: 2011 Edition by :
Issues in Cancer Drugs and Therapies / 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Cancer Drugs and Therapies. The editors have built Issues in Cancer Drugs and Therapies: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Cancer Drugs and Therapies in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Cancer Drugs and Therapies: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Author |
: |
Publisher |
: ScholarlyEditions |
Total Pages |
: 963 |
Release |
: 2013-05-01 |
ISBN-10 |
: 9781490108858 |
ISBN-13 |
: 1490108858 |
Rating |
: 4/5 (58 Downloads) |
Synopsis Issues in Cancer Treatment: 2013 Edition by :
Issues in Cancer Treatment / 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Gene Therapy. The editors have built Issues in Cancer Treatment: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Gene Therapy in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Cancer Treatment / 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Author |
: |
Publisher |
: ScholarlyEditions |
Total Pages |
: 39 |
Release |
: 2013-01-10 |
ISBN-10 |
: 9781481649537 |
ISBN-13 |
: 1481649531 |
Rating |
: 4/5 (37 Downloads) |
Synopsis Issues in Cancer Drugs and Therapies: 2012 Edition by :
Issues in Cancer Drugs and Therapies / 2012 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about Chemotherapy in a concise format. The editors have built Issues in Cancer Drugs and Therapies: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Chemotherapy in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Cancer Drugs and Therapies: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Author |
: |
Publisher |
: ScholarlyEditions |
Total Pages |
: 271 |
Release |
: 2013-05-01 |
ISBN-10 |
: 9781490108810 |
ISBN-13 |
: 1490108815 |
Rating |
: 4/5 (10 Downloads) |
Synopsis Issues in Cancer Drugs and Therapies: 2013 Edition by :
Issues in Cancer Drugs and Therapies / 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Gene Therapy. The editors have built Issues in Cancer Drugs and Therapies: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Gene Therapy in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Cancer Drugs and Therapies: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Author |
: Mario A. Dicato |
Publisher |
: Springer |
Total Pages |
: 512 |
Release |
: 2018-06-27 |
ISBN-10 |
: 9783319702537 |
ISBN-13 |
: 331970253X |
Rating |
: 4/5 (37 Downloads) |
Synopsis Side Effects of Medical Cancer Therapy by : Mario A. Dicato
This is the second edition of a well-received book that reflects the state of the art in cancer medical therapies and their side-effects, including immunotherapy and chemotherapeutic drugs. All chapters have been fully updated to include all the latest progress in drug discovery such as targeted therapies for each cancer type. From issues such as preservation of fertility to antiemetic therapy the book provides a very comprehensive overview of the field. The book includes a new chapter on immuno-oncology drugs. Organised by organ system, it lists the toxicity, side-effects and measures of prevention pertaining to each type of drug used in cancer therapy. The most dangerous side-effects are priority so as to alert the reader to their importance. Designed for quick reference in the clinical setting this book is primarily aimed at established medical oncologists but will also appeal to junior doctors, trainees, pharmacists and nurses.
Author |
: Eric H. Bernicker |
Publisher |
: Springer |
Total Pages |
: 186 |
Release |
: 2019-03-04 |
ISBN-10 |
: 9783030058555 |
ISBN-13 |
: 3030058557 |
Rating |
: 4/5 (55 Downloads) |
Synopsis Cancer and Society by : Eric H. Bernicker
While a number of books have looked at the intersection between human health in general and other topics, such as climate change or diet, this book focuses specifically on cancer as it impacts and is impacted by social justice issues. The massive explosion of research knowledge of cancer immunology and genomics is holding out great promise of therapeutic advances, yet other human actions—climate change, pollution, business decisions, advertising – are fostering health inequalities as well as increasing risks. Those involved in cancer care and research are in a unique position to let their experiences and knowledge inform the public, yet very often have not taken strong public roles when it comes to discussing issues surrounding tobacco, climate change and health risks, financial toxicity of treatments, and diet choices. Written by a multidisciplinary team of authors and for medical oncologists, cancer researchers, occupational health workers, and related medical students, residents, and fellows, this book encourages oncologists to address public health care and the societal issues associated with cancer risk. This volume discusses the overarching theme of environmental justice and oncology, focuses on business and cancer (such as clinical trials, drug development and profits, and global disparities), as well as animals and cancer.
Author |
: Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population |
Publisher |
: National Academies Press |
Total Pages |
: 0 |
Release |
: 2014-01-10 |
ISBN-10 |
: 0309286603 |
ISBN-13 |
: 9780309286602 |
Rating |
: 4/5 (03 Downloads) |
Synopsis Delivering High-Quality Cancer Care by : Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population
In the United States, approximately 14 million people have had cancer and more than 1.6 million new cases are diagnosed each year. However, more than a decade after the Institute of Medicine (IOM) first studied the quality of cancer care, the barriers to achieving excellent care for all cancer patients remain daunting. Care often is not patient-centered, many patients do not receive palliative care to manage their symptoms and side effects from treatment, and decisions about care often are not based on the latest scientific evidence. The cost of cancer care also is rising faster than many sectors of medicine--having increased to $125 billion in 2010 from $72 billion in 2004--and is projected to reach $173 billion by 2020. Rising costs are making cancer care less affordable for patients and their families and are creating disparities in patients' access to high-quality cancer care. There also are growing shortages of health professionals skilled in providing cancer care, and the number of adults age 65 and older--the group most susceptible to cancer--is expected to double by 2030, contributing to a 45 percent increase in the number of people developing cancer. The current care delivery system is poorly prepared to address the care needs of this population, which are complex due to altered physiology, functional and cognitive impairment, multiple coexisting diseases, increased side effects from treatment, and greater need for social support. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis presents a conceptual framework for improving the quality of cancer care. This study proposes improvements to six interconnected components of care: (1) engaged patients; (2) an adequately staffed, trained, and coordinated workforce; (3) evidence-based care; (4) learning health care information technology (IT); (5) translation of evidence into clinical practice, quality measurement and performance improvement; and (6) accessible and affordable care. This report recommends changes across the board in these areas to improve the quality of care. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis provides information for cancer care teams, patients and their families, researchers, quality metrics developers, and payers, as well as HHS, other federal agencies, and industry to reevaluate their current roles and responsibilities in cancer care and work together to develop a higher quality care delivery system. By working toward this shared goal, the cancer care community can improve the quality of life and outcomes for people facing a cancer diagnosis.
Author |
: Institute of Medicine |
Publisher |
: National Academies Press |
Total Pages |
: 95 |
Release |
: 2013-06-20 |
ISBN-10 |
: 9780309269445 |
ISBN-13 |
: 030926944X |
Rating |
: 4/5 (45 Downloads) |
Synopsis Delivering Affordable Cancer Care in the 21st Century by : Institute of Medicine
Rising health care costs are a central fiscal challenge confronting the United States. National spending on health care currently accounts for 18 percent of gross domestic product (GDP), but is anticipated to increase to 25 percent of GDP by 2037. The Bipartisan Policy Center argues that "this rapid growth in health expenditures creates an unsustainable burden on America's economy, with far-reaching consequences". These consequences include crowding out many national priorities, including investments in education, infrastructure, and research; stagnation of employee wages; and decreased international competitiveness.In spite of health care costs that far exceed those of other countries, health outcomes in the United States are not considerably better. With the goal of ensuring that patients have access to high-quality, affordable cancer care, the Institute of Medicine's (IOM's) National Cancer Policy Forum convened a public workshop, Delivering Affordable Cancer Care in the 21st Century, October 8-9, 2012, in Washington, DC. Delivering Affordable Cancer Care in the 21st Century summarizes the workshop.